Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp). The virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed
The state health department informed the High Court that in view of the ensuing festivals like Navaratri, Dussehra, Milad Un Nabi etc., a new containment policy has been prepared so that people won’t throw caution to the wind during the festive season. In the affidavit filed
Global Health, best known as the owner of Medanta, a chain of hospitals in north and east India, has sought the markets regulator’s approval for its initial public offering (IPO). As part of the IPO, Global Health, founded by Naresh Trehan, a cardiovascular surgeon, and Sunil Sachdeva, an entrepreneur, will sell new
Aurabeat, USFDA approved anti-Covid Class 2 medical device for SARS-COV-2 disinfection was launched in India today. Hong Kong-based Aurabeat has developed the patented AG+ five-stage sterilization purifying technology after extensive research in the field of air filtration for over a decade, Aurabeat’s AG+ Pro Silver
The Covid-19 pandemic has had a huge and everlasting impact on hospitals. Its outbreak in 2020, saw many hospitals shut their doors on their patients, and defer treatment and care, due to safety concerns. They partially opened up at the end of the year, but even
Apollo Hospitals begins offering the Antibody Cocktail (Casirivimab and Imdevimab) to patients with mild and moderate COVID and at high risk of developing severe COVID Indraprastha Apollo Hospitals, Delhi today announced that Roche India’s Antibody Cocktail (Casirivimab and Imdevimab) distributed by Cipla Ltd. is available for
